Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.67
+1.33 (3.39%)
Nov 21, 2024, 12:52 PM EST - Market open
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.10 billion as of November 21, 2024. Its market cap has increased by 47.11% in one year.
Market Cap
3.10B
Enterprise Value
2.21B
1-Year Change
47.11%
Ranking
Category
Stock Price
$40.67
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.10B, an increase of 2,080.63%. That is a compound annual growth rate of 35.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.96B | -1.72% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 3.00B |
| Inari Medical | 2.97B |
| Dyne Therapeutics | 2.96B |
| Merus | 2.96B |
| Amedisys | 2.95B |
| Vera Therapeutics | 2.92B |
| Edgewise Therapeutics | 2.89B |
| Surgery Partners | 2.87B |